Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Privia Health (PRVA) EBITDA Margin (2020 - 2025)

Privia Health has reported EBITDA Margin over the past 6 years, most recently at 2.11% for Q4 2025.

  • Quarterly results put EBITDA Margin at 2.11% for Q4 2025, up 93.0% from a year ago — trailing twelve months through Dec 2025 was 1.65% (up 61.0% YoY), and the annual figure for FY2025 was 1.65%, up 61.0%.
  • EBITDA Margin for Q4 2025 was 2.11% at Privia Health, down from 2.51% in the prior quarter.
  • Over the last five years, EBITDA Margin for PRVA hit a ceiling of 3.84% in Q1 2021 and a floor of 85.45% in Q2 2021.
  • Median EBITDA Margin over the past 5 years was 0.92% (2022), compared with a mean of 4.16%.
  • Biggest five-year swings in EBITDA Margin: tumbled -8906bps in 2021 and later surged 8398bps in 2022.
  • Privia Health's EBITDA Margin stood at 6.92% in 2021, then soared by 110bps to 0.7% in 2022, then crashed by -44bps to 0.39% in 2023, then soared by 205bps to 1.19% in 2024, then skyrocketed by 78bps to 2.11% in 2025.
  • The last three reported values for EBITDA Margin were 2.11% (Q4 2025), 2.51% (Q3 2025), and 0.68% (Q2 2025) per Business Quant data.